Clinical Trial

Immunomodulation During Pregnancy

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 19, 2025 (before its estimated March 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to learn about the effects of low dose aspirin in immunity Pregnant women taking aspirin for other reasons (preeclampsia prevention) will be studied. The main question it aims to answer is: evaluate the effect of LDA on the modulation of innate immunity cells (NK cells, monocytes, γδ T cells) and/or acquired immunity (B and T lymphocytes, Treg cells, Th cells). Participants already taking intervention A as part of their regular medical care for RA will answer online survey questions about their joint pain for 5 years.
Trial Details
NCT Number NCT06882850
Lead Sponsor Unidade Local de Saúde de Coimbra, EPE
Conditions Aspirin, Pregnancy Complications, Immunology
Enrollment 30 participants
Start Date 2024-02-01
Primary Completion 2025-03-30 (estimated)
Study Completion 2025-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-19